A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study (Q33329008)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q43249705)
(Q61278410)
(Q63101608)
(Q86719882)
(Q106724872)
(Q114304401)
(Q87988549)
(Q114292297)
(Q98207713)
(Q56685689)
(Q91980144)
(Q114304346)
(Q114304436)
(P304) 1543-1552
(P407) (Q1860)
(P433) 16
(P478) 51
(P577) Tuesday, April 1, 2008
(P921) (Q740)
(P1433) (Q2984355)
(P1476) "A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study" (language: en)
(P2093) John L Petersen
Peter J Fitzgerald
Charles A Simonton
Roger Gammon
Charles D O'Shaughnessy
Maurice Buchbinder
COSTAR II Investigators Group
other details
description scientific article

External Links